Economic evaluation of antenatal corticosteroid therapy prior to planned caesarean section at late preterm and term gestational ages

Project Code: 10464929

Faculty: Liggins Institute

Department: Liggins Institute

Main Supervisor: Dr Katie Groom (kgro017)

Application open date: 30 Jun 2020

Application deadline: 31 Oct 2020

Enrolment information: NZ Citizens, NZ Permanent Residents

Introduction

Birth by planned caesarean section compared to planned vaginal birth increases the risk of neonatal respiratory morbidity and the need for babies to be admitted to a neonatal unit.

Use of antenatal corticosteroids in women undergoing planned caesarean section at term or late preterm is supported by findings of improved neonatal respiratory morbidity in a limited number of randomised trials but may increase the risk of neonatal hypoglycaemia.

We are undertaking a large Health Research Council funded multicentre placebo-controlled trial to assess both the neonatal benefit and potential harm of maternal corticosteroid use prior to planned caesarean section at ≥35+0 to 39+6 weeks.

We aim to explore the effect of cost-effectiveness of this intervention as well as explore its potential health benefits.

What we are looking for in a successful applicant

Must meet the requirements for entry to a PhD programme.

Objective

To use data from the C*STEROID Trial to examine the cost-effectiveness of the use antenatal corticosteroids prior to planned caesarean section at term and late preterm gestations.

More about the C*STEROID Trial.

Other information

Scholarships may be available for this project and can be discussed with the potential supervisor.

Related opportunities